Results 201 to 210 of about 279,139 (356)
Abstract Aims Transthyretin amyloid cardiomyopathy (ATTR‐CM) is an increasinglyrecognized cause of heart failure with preserved ejection fraction (HFpEF), which may be diagnosed non‐invasively using 99mTc 3,3‐diphosphono‐1,2‐propanodicarboxylic acid (DPD) scintigraphy‐based diagnostic criteria.
L. Healy +15 more
wiley +1 more source
Gene Therapy for Cardiac Arrhythmias: Mechanisms, Modalities and Therapeutic Applications. [PDF]
Karakasis P +7 more
europepmc +1 more source
Noninvasive cardiac radiation for ablation of ventricular tachycardia [PDF]
Cooper, Daniel +12 more
core +2 more sources
Cardiac Purkinje fibers and arrhythmias; The GK Moe Award Lecture 2015 [PDF]
Penelope A. Boyden +2 more
openalex +1 more source
Interventional therapies for chronic heart failure: An overview of recent developments
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo +7 more
wiley +1 more source
Psychological Interventions for Reducing Distress in Patients with Cardiac Arrhythmias. [PDF]
Särnholm J +4 more
europepmc +1 more source
Cardiac arrhythmias in patients with Danon disease [PDF]
Torsten Konrad +8 more
openalex +1 more source
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri +12 more
wiley +1 more source
Role of ruxolitinib in preventing cardiac arrhythmias: A pooled analysis of clinical studies in hematology. [PDF]
Zaoli S +5 more
europepmc +1 more source

